Showing results (1871-1880 of 1,985) with videos related to

Sort By:
Pageof 199
The Lancet. Neurology|February 19, 2022
Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation studyPascal Benkert, Stephanie Meier, Sabine Schaedelin, et al.
The Lancet. Neurology|February 19, 2022
Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerationsBradley F Boeve, Adam L Boxer, Fiona Kumfor, et al.
The Lancet. Neurology|April 15, 2019
CSF and blood biomarkers for Parkinson's diseaseLucilla Parnetti, Lorenzo Gaetani, Paolo Eusebi, et al.
The Lancet. Neurology|January 22, 2022
Safety and efficacy of riluzole in spinocerebellar ataxia type 2 in France (ATRIL): a multicentre, randomised, double-blind, placebo-controlled trialGiulia Coarelli, Anna Heinzmann, Claire Ewenczyk, et al.
The Lancet. Neurology|January 30, 2022
Calcitonin gene-related peptide-targeting drugs for migraine: how pharmacology might inform treatment decisionsLinda Al-Hassany, Peter J Goadsby, A H Jan Danser, et al.
The Lancet. Neurology|March 19, 2022
Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt-Jakob disease: evaluation of a first-in-human treatment programmeSimon Mead, Azadeh Khalili-Shirazi, Caroline Potter, et al.
The Lancet. Neurology|September 29, 2018
Neuromodulation in the restoration of function after spinal cord injuryNicholas D James, Stephen B McMahon, Edelle C Field-Fote, et al.
The Lancet. Neurology|September 2, 2018
Pharyngeal electrical stimulation for early decannulation in tracheotomised patients with neurogenic dysphagia after stroke (PHAST-TRAC): a prospective, single-blinded, randomised trialRainer Dziewas, Rebecca Stellato, Ingeborg van der Tweel, et al.
The Lancet. Neurology|June 9, 2019
Pathophysiology, prevention, and treatment of medication overuse headacheHans-Christoph Diener, David Dodick, Stefan Evers, et al.
The Lancet. Neurology|May 25, 2019
Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trialKazunori Toyoda, Shinichiro Uchiyama, Takenori Yamaguchi, et al.
Pageof 199